Cargando…

Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269

Novel indolocarbazole derivatives named LCS were synthesized by our research group. Two of them were selected as the most active anticancer agents in vivo. We studied the mechanisms of anticancer activity in accordance with the previously described effects of indolocarbazoles. Cytotoxicity was estim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zenkov, Roman G., Vlasova, Olga A., Maksimova, Varvara P., Fetisov, Timur I., Karpechenko, Natalia Y., Ektova, Lidiya V., Eremina, Vera A., Popova, Valeriia G., Usalka, Olga G., Lesovaya, Ekaterina A., Belitsky, Gennady A., Yakubovskaya, Marianna G., Kirsanov, Kirill I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658795/
https://www.ncbi.nlm.nih.gov/pubmed/34885910
http://dx.doi.org/10.3390/molecules26237329
_version_ 1784612811937153024
author Zenkov, Roman G.
Vlasova, Olga A.
Maksimova, Varvara P.
Fetisov, Timur I.
Karpechenko, Natalia Y.
Ektova, Lidiya V.
Eremina, Vera A.
Popova, Valeriia G.
Usalka, Olga G.
Lesovaya, Ekaterina A.
Belitsky, Gennady A.
Yakubovskaya, Marianna G.
Kirsanov, Kirill I.
author_facet Zenkov, Roman G.
Vlasova, Olga A.
Maksimova, Varvara P.
Fetisov, Timur I.
Karpechenko, Natalia Y.
Ektova, Lidiya V.
Eremina, Vera A.
Popova, Valeriia G.
Usalka, Olga G.
Lesovaya, Ekaterina A.
Belitsky, Gennady A.
Yakubovskaya, Marianna G.
Kirsanov, Kirill I.
author_sort Zenkov, Roman G.
collection PubMed
description Novel indolocarbazole derivatives named LCS were synthesized by our research group. Two of them were selected as the most active anticancer agents in vivo. We studied the mechanisms of anticancer activity in accordance with the previously described effects of indolocarbazoles. Cytotoxicity was estimated by MTT assay. We analyzed LCS-DNA interactions by circular dichroism in cholesteric liquid crystals and fluorescent indicator displacement assay. The effect on the activity of topoisomerases I and II was studied by DNA relaxation assay. Expression of interferon signaling target genes was estimated by RT-PCR. Chromatin remodeling was analyzed–the effect on histone H1 localization and reactivation of epigenetically silenced genes. LCS-induced change in the expression of a wide gene set was counted by means of PCR array. Our study revealed the cytotoxic activity of the compounds against 11 cancer cell lines and it was higher than in immortalized cells. Both compounds bind DNA; binding constants were estimated—LCS-1208 demonstrated higher affinity than LCS-1269; it was shown that LCS-1208 intercalates into DNA that is typical for rebeccamycin derivatives. LCS-1208 also inhibits topoisomerases I and IIα. Being a strong intercalator and topoisomerase inhibitor, LCS-1208 upregulates the expression of interferon-induced genes. In view of LCSs binding to DNA we analyzed their influence on chromatin stability and revealed that LCS-1269 displaces histone H1. Our analysis of chromatin remodeling also included a wide set of epigenetic experiments in which LCS-1269 demonstrated complex epigenetic activity. Finally, we revealed that the antitumor effect of the compounds is based not only on binding to DNA and chromatin remodeling but also on alternative mechanisms. Both compounds induce expression changes in genes involved in neoplastic transformation and target genes of the signaling pathways in cancer cells. Despite of being structurally similar, each compound has unique biological activities. The effects of LCS-1208 are associated with intercalation. The mechanisms of LCS-1269 include influence on higher levels such as chromatin remodeling and epigenetic effects.
format Online
Article
Text
id pubmed-8658795
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86587952021-12-10 Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269 Zenkov, Roman G. Vlasova, Olga A. Maksimova, Varvara P. Fetisov, Timur I. Karpechenko, Natalia Y. Ektova, Lidiya V. Eremina, Vera A. Popova, Valeriia G. Usalka, Olga G. Lesovaya, Ekaterina A. Belitsky, Gennady A. Yakubovskaya, Marianna G. Kirsanov, Kirill I. Molecules Article Novel indolocarbazole derivatives named LCS were synthesized by our research group. Two of them were selected as the most active anticancer agents in vivo. We studied the mechanisms of anticancer activity in accordance with the previously described effects of indolocarbazoles. Cytotoxicity was estimated by MTT assay. We analyzed LCS-DNA interactions by circular dichroism in cholesteric liquid crystals and fluorescent indicator displacement assay. The effect on the activity of topoisomerases I and II was studied by DNA relaxation assay. Expression of interferon signaling target genes was estimated by RT-PCR. Chromatin remodeling was analyzed–the effect on histone H1 localization and reactivation of epigenetically silenced genes. LCS-induced change in the expression of a wide gene set was counted by means of PCR array. Our study revealed the cytotoxic activity of the compounds against 11 cancer cell lines and it was higher than in immortalized cells. Both compounds bind DNA; binding constants were estimated—LCS-1208 demonstrated higher affinity than LCS-1269; it was shown that LCS-1208 intercalates into DNA that is typical for rebeccamycin derivatives. LCS-1208 also inhibits topoisomerases I and IIα. Being a strong intercalator and topoisomerase inhibitor, LCS-1208 upregulates the expression of interferon-induced genes. In view of LCSs binding to DNA we analyzed their influence on chromatin stability and revealed that LCS-1269 displaces histone H1. Our analysis of chromatin remodeling also included a wide set of epigenetic experiments in which LCS-1269 demonstrated complex epigenetic activity. Finally, we revealed that the antitumor effect of the compounds is based not only on binding to DNA and chromatin remodeling but also on alternative mechanisms. Both compounds induce expression changes in genes involved in neoplastic transformation and target genes of the signaling pathways in cancer cells. Despite of being structurally similar, each compound has unique biological activities. The effects of LCS-1208 are associated with intercalation. The mechanisms of LCS-1269 include influence on higher levels such as chromatin remodeling and epigenetic effects. MDPI 2021-12-02 /pmc/articles/PMC8658795/ /pubmed/34885910 http://dx.doi.org/10.3390/molecules26237329 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zenkov, Roman G.
Vlasova, Olga A.
Maksimova, Varvara P.
Fetisov, Timur I.
Karpechenko, Natalia Y.
Ektova, Lidiya V.
Eremina, Vera A.
Popova, Valeriia G.
Usalka, Olga G.
Lesovaya, Ekaterina A.
Belitsky, Gennady A.
Yakubovskaya, Marianna G.
Kirsanov, Kirill I.
Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
title Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
title_full Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
title_fullStr Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
title_full_unstemmed Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
title_short Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
title_sort molecular mechanisms of anticancer activity of n-glycosides of indolocarbazoles lcs-1208 and lcs-1269
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658795/
https://www.ncbi.nlm.nih.gov/pubmed/34885910
http://dx.doi.org/10.3390/molecules26237329
work_keys_str_mv AT zenkovromang molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT vlasovaolgaa molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT maksimovavarvarap molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT fetisovtimuri molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT karpechenkonataliay molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT ektovalidiyav molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT ereminaveraa molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT popovavaleriiag molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT usalkaolgag molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT lesovayaekaterinaa molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT belitskygennadya molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT yakubovskayamariannag molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269
AT kirsanovkirilli molecularmechanismsofanticanceractivityofnglycosidesofindolocarbazoleslcs1208andlcs1269